First Horizon Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$35.2K Sell
677
-413
-38% -$23.5K ﹤0.01% 1188
2025
Q1
$69.6K Sell
1,090
-29
-3% -$1.69K ﹤0.01% 799
2024
Q4
$53.5K Sell
1,119
-171
-13% -$8.77K ﹤0.01% 922
2024
Q3
$73.8K Buy
1,290
+31
+2% +$1.78K ﹤0.01% 827
2024
Q2
$65.9K Sell
1,259
-186
-13% -$8.16K ﹤0.01% 811
2024
Q1
$58.8K Sell
1,445
-46
-3% -$1.72K ﹤0.01% 879
2023
Q4
$55.1K Buy
1,491
+293
+24% +$11K ﹤0.01% 894
2023
Q3
$45.8K Buy
1,198
+139
+13% +$5.69K ﹤0.01% 888
2023
Q2
$38.2K Buy
1,059
+280
+36% +$9.55K ﹤0.01% 1004
2023
Q1
$29.7K Buy
779
+140
+22% +$6.57K ﹤0.01% 1126
2022
Q4
$36.4K Sell
639
-79
-11% -$4.04K ﹤0.01% 990
2022
Q3
$28K Sell
718
-4
-0.6% -$177 ﹤0.01% 1081
2022
Q2
$32K Buy
722
+472
+189% +$20.4K ﹤0.01% 1103
2022
Q1
$10K Sell
250
-413
-62% -$14.7K ﹤0.01% 1094
2021
Q4
$25K Sell
663
-653
-50% -$24.4K ﹤0.01% 1191
2021
Q3
$52K Buy
1,316
+104
+9% +$4.35K ﹤0.01% 881
2021
Q2
$54K Sell
1,212
-191
-14% -$8.45K ﹤0.01% 751
2021
Q1
$57K Buy
1,403
+567
+68% +$25.9K ﹤0.01% 690
2020
Q4
$35K Buy
836
+527
+171% +$18.9K ﹤0.01% 715
2020
Q3
$8K Buy
309
+123
+66% +$3.42K ﹤0.01% 1056
2020
Q2
$5K Buy
+186
New +$4.2K ﹤0.01% 1167

Other funds holding HALO

First Horizon Advisors's HALO Position: Q2 2025 in Review

First Horizon Advisors reduced its Halozyme (HALO) stake by 38% in Q2 2025, selling an estimated $23.5K and leaving 677 shares worth $35.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1188.

First Horizon Advisors first reported a position in HALO in Q2 2020 and has held it in 21 quarters since. The position peaked at $73.8K in Q3 2024. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • First Horizon Advisors held 677 shares of Halozyme worth $35.2K as of Q2 2025.
  • First Horizon Advisors sold 413 Halozyme shares in Q2 2025, an estimated $23.5K.
  • Halozyme made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1188 holding.
  • First Horizon Advisors first reported a position in Halozyme in Q2 2020 and has held it in 21 quarters since.
  • First Horizon Advisors's Halozyme position peaked at $73.8K in Q3 2024.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.